In an AD mouse model induced by intracerebroventricular injection of amyloid-β oligomers (AβOs), ISRIB treatment counteracted the increase in ATF4 protein level, protecting mice from long-term memory impairment (Oliveira et al., 2021). The gene discussed is ATF4; the disease is Alzheimer disease.